May 2023 Publications
- Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis? Larsen SE, Baldwin SL, Coler RN. Int J Infect Dis. 2023 May. doi: 10.1016/j.ijid.2023.03.035. Epub 2023 Mar 23.
- Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience. Saluzzo F, Espinosa-Pereiro J, Dressler S, Tàvora Dos Santos Filho E, Seidel S, Gonzalez Moreno J, Heinrich N, Sanchez-Montalva A, Cirillo DM. Int J Infect Dis. 2023 May. doi: 10.1016/j.ijid.2023.03.008. Epub 2023 Mar 9.
- Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis-induced injury. Wang N, Liang Y, Ma Q, Mi J, Xue Y, Yang Y, Wang L, Wu X. Immun Inflamm Dis. 2023 May.doi: 10.1002/iid3.854
- Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study. Mao JJ, Zang X, Yue WL, Zhai PY, Zhang Q, Li CH, Zhuang X, Liu M, Qin G. BMJ Glob Health. 2023 May. doi: 10.1136/bmjgh-2023-012306.
- A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Protective Immune Responses in M. tuberculosis H37Ra Infected Mice. Wang J, Xie T, Ullah I, Mi Y, Li X, Gong Y, He P, Liu Y, Li F, Li J, Lu Z, Zhu B. Vaccines (Basel). 2023 May 4. doi: 10.3390/vaccines11050941.
- Newborn bacille Calmette-Guérin vaccination induces robust infant interferon-γ-expressing natural killer cell responses to mycobacteria. Murphy M, Suliman S, Briel L, Veldtsman H, Khomba N, Africa H, Steyn M, Snyders CI, van Rensburg IC, Walzl G, Chegou NN, Hatherill M, Hanekom WA, Scriba TJ, Nemes E. Int J Infect Dis. 2023 May. doi: 10.1016/j.ijid.2023.02.018. Epub 2023 Feb 25.
- Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against Mycobacterium tuberculosis H37Rv: an immuno-informatics approach. Kumar A, Sharma P, Arun A, Meena LS. J Biomol Struct Dyn. 2023 May. doi: 10.1080/07391102.2022.2048079. Epub 2022 Mar 16.
- Advances in development of new tuberculosis vaccines. da Costa C, Onyebujoh P, Thiry G, Zumla A. Curr Opin Pulm Med. 2023 May 1. doi: 10.1097/MCP.0000000000000950. Epub 2023 Mar 2.
- The tuberculosis vaccine challenge. Bull World Health Org. 2023 May 1. doi: 10.2471/BLT.23.02053.
- BCG is protective against death in male but not female patients with pulmonary tuberculosis in Guinea-Bissau. Bohlbro AS, Mendes AM, Sifna A, Patsche CB, Soelberg MES, Gomes V, Wejse C, Rudolf F. Trans R Soc Trop Med Hyg. 2023 May 2. doi: 10.1093/trstmh/trac120.
- Role of B Cells in Mycobacterium Tuberculosis Infection. Stewart P, Patel S, Comer A, Muneer S, Nawaz U, Quann V, Bansal M, Venketaraman V. Vaccines (Basel). 2023 May 6. doi: 10.3990/vacciness11050955.
- BCG∆BCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice. Aceves-Sánchez MJ, Barrios-Payán JA, Segura-Cerda CA, Flores-Valdez MA, Mata-Espinosa D, Pedroza-Roldán C, Yadav R, Saini DK, de la Cruz MA, Ares MA, Bielefeldt-Ohmann H, Baay-Guzmán G, Vergne I, Velázquez-Fernández JB, Barba León J, Hernández-Pando R. Vaccine. 2023 May 8. doi: 10.1016/j.vaccine.2023.04.065. Online ahead of print.
- A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG. Dijkman K, Lindenstrøm T, Rosenkrands I, Søe R, Woodworth JS, Lindestam Arlehamn CS, Mortensen R. NPJ Vaccines. 2023 May 9. doi: 10.1038/s41541-023-00666-2.
- Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Choi YH, Kang YA, Park KJ, Choi JC, Cho KG, Ko DY, Ahn JH, Lee B, Ahn E, Woo YJ, Jung K, Kim NY, Reese VA, Larsen SE, Baldwin SL, Reed SG, Coler RN, Lee H, Cho SN. Infect Dis Ther. 2023 May 11. doi: 10.1007/s40121-023-00806-0. Online ahead of print.
- Role of MAIT cells in immunity against Mycobacterium tuberculosis. [Article in Chinese]. Cao ZH, Cheng XX.Zhonghua Jie He He Hu Xi Za Zhi. 2023 May 12. doi: 10.3760/cma.j.cn112147-20230307-00117.
- Host genetic background is a barrier to broadly effective vaccine-mediated protection against tuberculosis. Lai R, Gong DN, Williams T, Ogunsola AF, Cavallo K, Arlehamn CSL, Acolatse S, Beamer G, Ferris MT, Sassetti CM, Lauffenburger DA, Behar SM. J Clin Invest. 2023 May 18. doi: 10.1172/JCI167762.
- A candidate subunit vaccine induces protective immunity against Mycobacterium avium subspecies paratuberculosis in mice. Shao M, Cui N, Tang Y, Chen F, Cui Y, Dang G, Liu S. NPJ. 2023 May 20. doi: 10.1038/s41541-023-00675-1.
- Vaccines against Tuberculosis: Where Are We Now? Srivastava S, Dey S, Mukhopadhyay S. Vaccine (Basel). 2023 May 22. doi: 10.3390/vaccines11051013.
- Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates. Wang R, Fan X, Jiang Y, Li G, Li M, Zhao X, Luan X, Deng Y, Chen Z, Liu H, Wan K. Vaccines. 2023 May 22. doi: 10.1016/j.vaccine.2023.04.003. Online ahead of print.
- Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques. Darrah PA, Zeppa JJ, Wang C, Irvine EB, Bucsan AN, Rodgers MA, Pokkali S, Hackney JA, Kamath M, White AG, Borish HJ, Frye LJ, Tomko J, Kracinovsky K, Lin PL, Klein E, Scanga CA, Alter G, Fortune SM, Lauffenburger DA, Flynn JL, Seder RA, Maiello P, Roederer M. Cell Host Microbe. 2023 May 23. doi: 10.1016/j.chom.2023.05.006. Online ahead of print.
- Heterologous production of the D-cycloserine intermediate O-acetyl-L-serine in a human type II pulmonary cell model. Robbins L, Balaram A, Dejneka S, McMahon M, Najibi Z, Pawlowicz P, Conrad, WH. Sci Rep. 2023 May 26. doi: 10.1038/s41598-023-35632-4.
- Non-restrictive open vial policy combined with the home visit vaccinations for improving BCG coverage in a high-incidence outreach region: A model-based cost-effectiveness analysis for Indonesia. Machlaurin A, Luttjeboer J, Setiawan D, van der Werf TS. Postma MJ. J Glob Health. 2023 May 26. doi: 10.7189/jogh.13.04049.
- Mycobacterial Genetic Technologies for Probing the Host-Pathogen Microenvironment. Adefisayo OO, Curtis ER, Smith CM. Infect Immun. 2023 May 30. doi: 10.1128/iai.00430-22. Online ahead of print.